Tag: drugs
-
AI pharma start-up BenevolentAI now worth $2 billion after $115 million funding boost
British artificial intelligence start-up BenevolentAI has bagged $115 million from investors, lifting its pre-money valuation to $2 billion. The London-based firm, which is focused on the pharmaceutical industry, said the latest round of funding will help it scale drug development and its AI platform. The company currently has more than 20 drug programs. It said…
-
Biopharma Innovation — Value At Any Price?
In March I attended The Conference Forum’s R&D Leadership Summit. One of the panels that provided a great deal of insight involved executives discussing how to assess and create value for patients, payors, regulators, and society. This event employs the Chatham House Rule, which means “Neither the identity nor the affiliation of the speaker(s), nor that…
Hoje Investe em Inovadores 